Evidence map›Paper›PMID 30709374›Full record

ArticleBMC health services research2019

China's new policy for healthcare cost-control based on global budget: a survey of 110 clinicians in hospitals.

Jianzhou Yan, Hui-Heng Lin, Dan Zhao, Yuanjia Hu, Rong Shao

Abstract read
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. New evidence on supplier-induced demand in China's public tertiary hospitals: is the cost of hospitalization higher in the off-season?The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianzhou YanSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China.
Hui-Heng LinState Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Room 2053, N22, Taipa, 999078, Macau, People's Republic of China.
Dan ZhaoSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China.
Yuanjia HuThe Research Center of National Drug Policy and Ecosystem, China Pharmaceutical University, Nanjing, Jiangsu, 211198, People's Republic of China. yuanjiahu@umac.mo.ORCID http://orcid.org/0000-0001-5244-8577
Rong ShaoSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China. shaorong118@163.com.

Funding

Fundo para o Desenvolvimento das Ciências e da Tecnologia FDCT013/2015/A1National social science foundation of the national planning office for philosophy and social sciences 15ZDB167Universidade de Macau MYRG2015-00172-ICMS-QRCMUniversidade de Macau MYRG2016-00144-ICMS-QRCM
6 · The paper itself

Abstract

backgroundThe increasing cost on healthcare exposes China's healthcare budgets and system to financial crisis. To control the excessive growth of healthcare expenditure, China's healthcare reforms emphasize the control of the global budget for healthcare, which leads to the release of relevant policy and a series of cost-control actions implemented by different hospitals. This work aims to identify the effects brought by the cost-control policy and actions via surveying and analysing feedback from clinicians.

methodsQuestionnaires on the cost-control policy and actions were designed for surveying 110 clinicians in hospitals from different regions of China. The data on the implementation of the cost-control actions and doctors' feedback on these actions were analysed using descriptive statistics. Pearson's chi-squared tests were performed to detect associations between doctors' opinions and specific cost-control actions. A value of p < 0.05 was considered statistically significant. Association relationships between doctors' opinions and cost-control actions were modelled into network models, and key factors were identified in a multi-variate framework. Last, we visualized our resultant data using a network model, and further multi-variate analysis was performed.

resultsThere were three main findings. (1) The cost-control policy has been widely implemented in the sampled hospitals in different regions of China, with more than 80% of those surveyed acknowledging that their hospitals take actions of reducing average prescription fees for outpatients, drug costs, and in-hospitalization durations. (2) Most doctors have a negative view of some cost-control actions; this is mainly due to concerns about the effects of these actions on the doctors' own healthcare performance and patient satisfaction. (3) Cost-control actions that had a significant impact on doctors' performance included limiting average prescription fees for outpatients and limiting the use of examinations/drugs/surgeries. Decreased patient satisfaction was associated with fewer admissions of critically ill patients, reduced use of brand-name drugs, and increased total costs to patients due to increased frequencies of visits to the hospitals.

conclusionsCost-control actions implemented in hospitals in response to the government's policy to reduce its national healthcare budget affect both doctors and patients in several ways. Moreover, the cost-control policy and actions can be improved.

Indexed as

Ambulatory CareAttitude of Health PersonnelBudgetsChinaCost ControlDrug CostsEconomics, HospitalHealth Care ReformHealth PolicyHospitalsHumansOutpatientsPatient SatisfactionPhysiciansPrescription FeesSurveys and QuestionnairesChina healthcare budget crisisClinician surveyHealthcare cost-control policyHealthcare performanceHospitals’ healthcare cost-control actionsPatient satisfaction

Identifiers

PMID30709374
PMCPMC6357408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.